Global BCG Tuberculosis (TB) Vaccine Market Research Report 2020

Global BCG Tuberculosis (TB) Vaccine Market Research Report 2020

Table of Contents
1 BCG Tuberculosis (TB) Vaccine Market Overview
1.1 Product Overview and Scope of BCG Tuberculosis (TB) Vaccine
1.2 BCG Tuberculosis (TB) Vaccine Segment by Type
1.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Immune BCG
1.2.3 Therapy BCG
1.3 BCG Tuberculosis (TB) Vaccine Segment by Application
1.3.1 BCG Tuberculosis (TB) Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global BCG Tuberculosis (TB) Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Tuberculosis (TB) Vaccine Revenue 2015-2026
1.4.2 Global BCG Tuberculosis (TB) Vaccine Sales 2015-2026
1.4.3 BCG Tuberculosis (TB) Vaccine Market Size by Region: 2020 Versus 2026
2 Global BCG Tuberculosis (TB) Vaccine Market Competition by Manufacturers
2.1 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global BCG Tuberculosis (TB) Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers BCG Tuberculosis (TB) Vaccine Manufacturing Sites, Area Served, Product Type
2.5 BCG Tuberculosis (TB) Vaccine Market Competitive Situation and Trends
2.5.1 BCG Tuberculosis (TB) Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key BCG Tuberculosis (TB) Vaccine Players (Opinion Leaders)
3 BCG Tuberculosis (TB) Vaccine Retrospective Market Scenario by Region
3.1 Global BCG Tuberculosis (TB) Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global BCG Tuberculosis (TB) Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.3.1 North America BCG Tuberculosis (TB) Vaccine Sales by Country
3.3.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.4.1 Europe BCG Tuberculosis (TB) Vaccine Sales by Country
3.4.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Region
3.5.2 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.6.1 Latin America BCG Tuberculosis (TB) Vaccine Sales by Country
3.6.2 Latin America BCG Tuberculosis (TB) Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country
3.7.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global BCG Tuberculosis (TB) Vaccine Historic Market Analysis by Type
4.1 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2015-2020)
4.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global BCG Tuberculosis (TB) Vaccine Price Market Share by Type (2015-2020)
4.4 Global BCG Tuberculosis (TB) Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global BCG Tuberculosis (TB) Vaccine Historic Market Analysis by Application
5.1 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2015-2020)
5.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global BCG Tuberculosis (TB) Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in BCG Tuberculosis (TB) Vaccine Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi Pasteur Products Offered
6.2.5 Sanofi Pasteur Recent Development
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.3.2 Japan BCG Lab Description, Business Overview and Total Revenue
6.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Japan BCG Lab Products Offered
6.3.5 Japan BCG Lab Recent Development
6.4 China National Biotec
6.4.1 China National Biotec BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.4.2 China National Biotec Description, Business Overview and Total Revenue
6.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 China National Biotec Products Offered
6.4.5 China National Biotec Recent Development
6.5 Serum Institute of India
6.5.1 Serum Institute of India BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.5.2 Serum Institute of India Description, Business Overview and Total Revenue
6.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Serum Institute of India Products Offered
6.5.5 Serum Institute of India Recent Development
6.6 Intervax
6.6.1 Intervax BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.6.2 Intervax Description, Business Overview and Total Revenue
6.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Intervax Products Offered
6.6.5 Intervax Recent Development
6.7 GSBPL
6.6.1 GSBPL BCG Tuberculosis (TB) Vaccine Production Sites and Area Served
6.6.2 GSBPL Description, Business Overview and Total Revenue
6.6.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GSBPL Products Offered
6.7.5 GSBPL Recent Development
7 BCG Tuberculosis (TB) Vaccine Manufacturing Cost Analysis
7.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of BCG Tuberculosis (TB) Vaccine
7.4 BCG Tuberculosis (TB) Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 BCG Tuberculosis (TB) Vaccine Distributors List
8.3 BCG Tuberculosis (TB) Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global BCG Tuberculosis (TB) Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of BCG Tuberculosis (TB) Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of BCG Tuberculosis (TB) Vaccine by Type (2021-2026)
10.2 BCG Tuberculosis (TB) Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of BCG Tuberculosis (TB) Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of BCG Tuberculosis (TB) Vaccine by Application (2021-2026)
10.3 BCG Tuberculosis (TB) Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of BCG Tuberculosis (TB) Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of BCG Tuberculosis (TB) Vaccine by Region (2021-2026)
10.4 North America BCG Tuberculosis (TB) Vaccine Estimates and Projections (2021-2026)
10.5 Europe BCG Tuberculosis (TB) Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific BCG Tuberculosis (TB) Vaccine Estimates and Projections (2021-2026)
10.7 Latin America BCG Tuberculosis (TB) Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa BCG Tuberculosis (TB) Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global BCG Tuberculosis (TB) Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key BCG Tuberculosis (TB) Vaccine Manufacturers Covered in This Study
Table 5. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global BCG Tuberculosis (TB) Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global BCG Tuberculosis (TB) Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global BCG Tuberculosis (TB) Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market BCG Tuberculosis (TB) Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers BCG Tuberculosis (TB) Vaccine Sales Sites and Area Served
Table 11. Manufacturers BCG Tuberculosis (TB) Vaccine Product Types
Table 12. Global BCG Tuberculosis (TB) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global BCG Tuberculosis (TB) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCG Tuberculosis (TB) Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key BCG Tuberculosis (TB) Vaccine Players
Table 16. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global BCG Tuberculosis (TB) Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America BCG Tuberculosis (TB) Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America BCG Tuberculosis (TB) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global BCG Tuberculosis (TB) Vaccine Sales Share by Type (2015-2020)
Table 42. Global BCG Tuberculosis (TB) Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2015-2020)
Table 44. Global BCG Tuberculosis (TB) Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global BCG Tuberculosis (TB) Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Merck BCG Tuberculosis (TB) Vaccine Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Corporation Information
Table 54. Sanofi Pasteur Corporation Information
Table 55. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Pasteur Main Product
Table 57. Sanofi Pasteur Recent Development
Table 58. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Corporation Information
Table 59. Japan BCG Lab Corporation Information
Table 60. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Japan BCG Lab Main Product
Table 62. Japan BCG Lab Recent Development
Table 63. China National Biotec BCG Tuberculosis (TB) Vaccine Corporation Information
Table 64. China National Biotec Corporation Information
Table 65. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. China National Biotec Main Product
Table 67. China National Biotec Recent Development
Table 68. Serum Institute of India BCG Tuberculosis (TB) Vaccine Corporation Information
Table 69. Serum Institute of India Corporation Information
Table 70. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Serum Institute of India Main Product
Table 72. Serum Institute of India Recent Development
Table 73. Intervax BCG Tuberculosis (TB) Vaccine Corporation Information
Table 74. Intervax Corporation Information
Table 75. Intervax BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Intervax Main Product
Table 77. Intervax Recent Development
Table 78. GSBPL BCG Tuberculosis (TB) Vaccine Corporation Information
Table 79. GSBPL Corporation Information
Table 80. GSBPL BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. GSBPL Main Product
Table 82. GSBPL Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. BCG Tuberculosis (TB) Vaccine Distributors List
Table 86. BCG Tuberculosis (TB) Vaccine Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 91. Global BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 92. Global BCG Tuberculosis (TB) Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global BCG Tuberculosis (TB) Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global BCG Tuberculosis (TB) Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global BCG Tuberculosis (TB) Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 98. Global BCG Tuberculosis (TB) Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of BCG Tuberculosis (TB) Vaccine
Figure 2. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Immune BCG Product Picture
Figure 4. Therapy BCG Product Picture
Figure 5. Global BCG Tuberculosis (TB) Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global BCG Tuberculosis (TB) Vaccine Market Size 2015-2026 (US$ Million)
Figure 9. Global BCG Tuberculosis (TB) Vaccine Sales Capacity (K Units) (2015-2026)
Figure 10. Global BCG Tuberculosis (TB) Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 11. BCG Tuberculosis (TB) Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global BCG Tuberculosis (TB) Vaccine Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by BCG Tuberculosis (TB) Vaccine Revenue in 2019
Figure 14. BCG Tuberculosis (TB) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region in 2019
Figure 17. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region in 2019
Figure 19. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country in 2019
Figure 20. North America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country in 2019
Figure 21. U.S. BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Country in 2019
Figure 26. Europe BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country in 2019
Figure 27. Germany BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 30. France BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Region in 2019
Figure 38. Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region in 2019
Figure 39. China BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. China BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. India BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country in 2019
Figure 62. Latin America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country in 2019
Figure 63. Mexico BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Country in 2019
Figure 70. Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country in 2019
Figure 71. Turkey BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E BCG Tuberculosis (TB) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E BCG Tuberculosis (TB) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of BCG Tuberculosis (TB) Vaccine by Type (2015-2020)
Figure 78. Sales Market Share of BCG Tuberculosis (TB) Vaccine by Type in 2019
Figure 79. Revenue Share of BCG Tuberculosis (TB) Vaccine by Type (2015-2020)
Figure 80. Revenue Market Share of BCG Tuberculosis (TB) Vaccine by Type in 2019
Figure 81. Global BCG Tuberculosis (TB) Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2015-2020)
Figure 83. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of BCG Tuberculosis (TB) Vaccine by Application (2015-2020)
Figure 85. Global Revenue Share of BCG Tuberculosis (TB) Vaccine by Application in 2020
Figure 86. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Japan BCG Lab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. China National Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Intervax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GSBPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Price Trend of Key Raw Materials
Figure 94. Manufacturing Cost Structure of BCG Tuberculosis (TB) Vaccine
Figure 95. Manufacturing Process Analysis of BCG Tuberculosis (TB) Vaccine
Figure 96. BCG Tuberculosis (TB) Vaccine Industrial Chain Analysis
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Porter's Five Forces Analysis
Figure 100. North America BCG Tuberculosis (TB) Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. North America BCG Tuberculosis (TB) Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Europe BCG Tuberculosis (TB) Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Europe BCG Tuberculosis (TB) Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Latin America BCG Tuberculosis (TB) Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America BCG Tuberculosis (TB) Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs